Goldman Sachs Maintains Neutral on Zymergen, Lowers Price Target to $4
Goldman Sachs maintains Zymergen (NASDAQ:ZY) with a Neutral and lowers the price target from $6 to $4.
Stocks That Hit 52-Week Lows On Friday
During Friday's morning session, 234 stocks hit new 52-week lows.
Goldman Sachs Maintains Neutral on Zymergen, Lowers Price Target to $6
Goldman Sachs maintains Zymergen (NASDAQ:ZY) with a Neutral and lowers the price target from $10.5 to $6.
Zymergen Q4 EPS $(0.76) Misses $(0.72) Estimate, Sales $3.04M Beat $2.92M Estimate
Zymergen (NASDAQ:ZY) reported quarterly losses of $(0.76) per share which missed the analyst consensus estimate of $(0.72) by 5.56 percent. The company reported quarterly sales of $3.04 million which beat the analyst
